Amphastar Pharmaceuticals (AMPH) Return on Sales: 2014-2025
Historic Return on Sales for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to 0.14%.
- Amphastar Pharmaceuticals' Return on Sales fell 8.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of 0.20% for FY2024, which is 1.00% down from last year.
- Latest data reveals that Amphastar Pharmaceuticals reported Return on Sales of 0.14% as of Q3 2025, which was down 18.84% from 0.17% recorded in Q2 2025.
- Over the past 5 years, Amphastar Pharmaceuticals' Return on Sales peaked at 0.23% during Q2 2024, and registered a low of 0.00% during Q1 2021.
- In the last 3 years, Amphastar Pharmaceuticals' Return on Sales had a median value of 0.20% in 2024 and averaged 0.20%.
- As far as peak fluctuations go, Amphastar Pharmaceuticals' Return on Sales fell by 21bps in 2021, and later rose by 18bps in 2022.
- Amphastar Pharmaceuticals' Return on Sales (Quarterly) stood at 0.15% in 2021, then climbed by 3bps to 0.18% in 2022, then climbed by 4bps to 0.21% in 2023, then declined by 1bps to 0.20% in 2024, then declined by 8bps to 0.14% in 2025.
- Its last three reported values are 0.14% in Q3 2025, 0.17% for Q2 2025, and 0.18% during Q1 2025.